Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population

Prenatal Diagnosis

Volumn 33, Issue 11, 2013, Pages 1070-1074

  Diguisto, Caroline ^a,b   Le Gouge, Amélie ^b,c   Piver, Eric ^a   Giraudeau, Bruno ^b,c   Perrotin, Franck ^a,b  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; ENDOGLIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; PLACENTAL GROWTH FACTOR; TRIACYLGLYCEROL; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; UTERINE ARTERY;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; MATERNAL SERUM SCREENING TESTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PROGNOSIS; RECEPTORS, CELL SURFACE; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84886587128     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4198     Document Type: Article

References (20)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365(9461):785-99.
2. Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev (Online) 2007;(2):CD004659, DOI: 10.1002/14651858.CD004659.pub2.
3. Roberge S, Giguere Y, Villa P, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2013.
4. Antenatal Care : Routine Care for the Healthy Pregnant Woman. London: National Collaborating Centre for Women's and Children's Health, 2008.
5. Poon LC, Kametas NA, Chelemen T, et al. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 2010;24(2):104-10.
6. Kleinrouweler C, Wiegerinck M, Ris-Stalpers C, et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 2012;119(7):778-87.
7. Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011;31(1):66-74.
8. Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008;178(6):701-11.
9. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(1):S1-22.
10. Giguere Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Ann Biol Clin 2011;69(3):257-71.
11. Blondel B, Lelong N, Kermarrec M, et al. Trends in perinatal health in France between 1995 and 2010: Results from the National Perinatal Surveys. J Gynecol Obstet Biol Reprod 2012;41(2):151-66.
12. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33(3):130-7.
13. Winer N, Branger B. Management of preeclampsia in a perinatal network. Ann Fr Anesth Reanim 2010;29(4):e47-50.
14. James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol 2010;221(4):363-78.
15. Verlohren S, Herraiz I, Lapaire O, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012;206(1):58 e1-8.
16. Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet 2010;376(9741):631-44.
17. Demirci O, Tugrul AS, Dolgun N, et al. Serum lipids level assessed in early pregnancy and risk of pre-eclampsia. J Obstet Gynaecol Res 2011;37(10):1427-32.
18. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG 2001;108(10):1081-7.
19. Anim-Nyame N, Sooranna SR, Steer PJ, et al. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod (Oxford, England) 2000;15(9):2033-6.
20. Salomon LJ, Benattar C, Audibert F, et al. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003;189(6):1517-22.